Company Profile:
PHARBACO THAL BINH PHARMACEUTICAL, also widely known as Binh Dinh Pharmaceutical Joint Stock Company (Bidiphar), is primarily a **manufacturer (factory)**.
Company Introduction:
Bidiphar is one of Vietnam's leading and most established pharmaceutical companies, with a rich history dating back to 1971. Headquartered in Binh Dinh Province, Vietnam, the company specializes in the research, development, manufacturing, marketing, and distribution of a diverse range of pharmaceutical products.
Key characteristics and activities include:
A Dedicated Manufacturer: Bidiphar operates multiple state-of-the-art manufacturing facilities. These factories adhere to stringent international quality standards, including WHO Good Manufacturing Practice (GMP-WHO), Good Laboratory Practice (GLP), and Good Storage Practice (GSP), ensuring high-quality and safe products.
Extensive Product Portfolio: The company produces a broad spectrum of pharmaceutical items, which typically include modern western medicines (such as injectables, tablets, capsules, and oral solutions), traditional oriental medicines, biotechnological products, and health supplements.
Research and Development Focus: Bidiphar invests significantly in R&D to innovate and expand its product offerings, aiming to meet evolving healthcare needs.
Market Reach: The company serves both the domestic Vietnamese market and has an expanding presence in international markets, exporting its products to various countries.
Commitment to Healthcare: Bidiphar is recognized for its long-standing commitment to improving public health through the provision of effective and reliable pharmaceutical solutions.